Non invasive medical diagnostics company Know Labs Inc has come into the radars of many investors in recent times and on Thursday, the rally continued in the company’s stock. Yesterday, the Know Labs (OTCMKTS:KNWN) stock was in sharp focus and managed to clock gains of 27%, which took its gains for the past month to a staggering 110%.
The latest rally in the stock has possibly been triggered by the announcement from the company earlier on this week about the granting of another patent for its technology Bio-FRID. It is a major development for the company considering the fact that it has now taken its count of pending and issued patents to as many as 57.
The inventor of Bio-FRID and the Chief Executive Officer of Know Labs Phil Bosue spoke about the development as well. He stated that that company is involved in creating a breakthrough platform technology that could eventually revolutionise the world of medical diagnostics.
The latest patent that was granted to the company for Bio-FRID is vital since it is going to help the technology in controlling the timing of frequency capture, an important element in a technology of this nature. It remains to be seen if the Know Labs stock can end the week strongly.
Market Reaction:
On Thursday, KNWN stock gained 27% to $4 with more than 155K shares, compared to its average volume of 50k shares. The stock has moved within a range of $3.2000 – 4.0000 after opening the trade at $3.25. Over the past 52-week, the stock has been trading within a range of $1.1000 – 4.8300.